HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Unilever acquires Sara Lee's personal-care business

This article was originally published in The Rose Sheet

Executive Summary

Consumer products firm announced Sept. 25 its $1.88 billion offer to purchase the global personal-care business of Sara Lee Corp. Sara Lee's global body-care portfolio includes products Sanex, Radox and Duschdas, and generates annual sales of more than $1 billion, according to the firm. "Personal care is a strategic category and a key growth driver for Unilever," says Unilever CEO Paul Polman. "This transaction builds on our portfolio in Western Europe and also in Asia. The Sara Lee brands enjoy strong consumer recognition, offer significant growth potential and are an excellent fit with Unilever's existing business." The transaction is expected to close in early 2010, according to Downers Grove, Ill.-based Sara Lee. "The divestiture of body care and European detergents would advance our strategy to concentrate on our core food and beverage business where we enjoy a strong competitive position and where we can generate superior shareholder returns," says Chairman and CEO Brenda C. Barnes. "We intend to use the proceeds from the divestiture to invest for growth in our core businesses and to repurchase stock.

Latest Headlines
See All
UsernamePublicRestriction

Register

RS016445

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel